Sign in

Ann-Kathrin Mehnert

@ak-mehnert.bsky.social
50 followers 84 following 1 posts

📍 Heidelberg / Frankfurt am Main 🤓 Scientific coordinator @Georg-Speyer-Haus 🧬 PhD in molecular biology and virology 💬 Passionate about science management, communication, and education

PostsRepliesMedia
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 08/10/2026
Save the date! 📢 1st International Conference on Cell Plasticity in Colorectal Cancer 📅 Oct 2–7, 2027 🇬🇷 Chania, Crete Exploring how cellular plasticity, the tumor microenvironment & microbiome shape colorectal cancer. 👉 tinyurl.com/38s9x2k8 #TRR417 #TogetherAgainstColonCancer #ColorectalCancer
011
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 04/09/2026
Day 3 of the #FrankfurtCancerConference brought new perspectives on tumor plasticity, drug design and metastasis, with lively exchange during Poster Session II. Douglas Hanahan delivered an inspiring final keynote, followed by the Poster Prize Awards. Thank you to all who joined us! See you in 2028!
141
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 03/09/2026
Day 2 of the #FrankfurtCancerConference focused on drug design, tumor plasticity, the microbiome and hematological malignancies. Thanks to today’s speakers! The day was rounded off with Poster Session I and the UCT-organized MSNZ Career Event with @maria-sibilia.bsky.social and Ihsan Ekin Demir!
291
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 02/09/2026
Day 1 of the #FrankfurtCancerConference! Carl June opened the conference with a keynote setting the stage for 2 sessions on Advances in Immuno-Oncology. Thanks to today's fantastic speakers! It was great to see the FCI community so strongly represented. Looking forward to Day 2! 📸 UCT, F. Cremer
152
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 13/05/2026
✨ Keynote spotlight of the #FrankfurtCancerConference 2026: Prof. Carl June, pioneer in CAR T cell therapy and #immunotherapy @upenn.edu. His groundbreaking work led to CTL019, the first FDA-approved CAR T cell therapy in the US. 👉 Register until June 25, 2026! 🔗 www.frankfurtcancerconference.org
153
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 28/04/2026
It’s the final day of our miniseries “It All Starts with Curiosity” for🧪World Laboratory Day+our last puzzle featuring a cropped image – almost as vibrant as Marc Chagall’s blue stained-glass🪟windows in Mainz. A little hint ➡️ georg-speyer-haus.de/forschung/fo... or ➡️ fci.health Good🍀luck guessing!
152
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 27/04/2026
🌴 Wrapping up #AACR26: what a memorable experience! 🤝 Thanks to everyone who visited our booth and connected with us. Special thanks to @dfg.de North America for the invite and to Dean Barbara Jung from the @ucsdmedschool.bsky.social for a special evening reception. #TogetherAgainstColonCancer
042
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 22/04/2026
Keep guessing with us on Day 3️⃣ of our mini-series “It All Starts with Curiosity” for 🧪World Laboratory Day🧫🥼 on April 2️⃣3️⃣. The answer will once again be revealed tomorrow morning before the next puzzle. Good 🍀luck and have fun! More➡️ www.linkedin.com/posts/proloe...
152
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 22/04/2026
Ratet mit, auch an Tag 3️⃣ unserer Miniserie „Alles beginnt mit Neugier“ zum🧪Welttag des Labors🧫🥼am 2️⃣3️⃣. April. Die 💡Lösung wird wieder morgen früh vor dem nächsten Rätsel bekannt gegeben. Viel Spaß beim Mitmachen! Mehr ➡️ www.linkedin.com/posts/proloe...
194
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 20/04/2026
Zum🗺️Welttag des🧪Labors🧫🥼23.04. starten wir heute unsere Miniserie „Alles beginnt mit Neugier“. Wir zeigen Euch die Welt der LOEWE-Forschung – Ihr seid herzlich eingeladen mitzumachen. ✍🏽Eure Antworten gerne in die Kommentarzeile. Die Lösung gibt’s morgen früh, mehr ➡️ www.linkedin.com/posts/proloe...
1113
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 20/04/2026
📍 We made it to #AACR26 in San Diego! Visit us at Booth 3045 (Cancer Research in Germany) to learn about translational colorectal cancer research & opportunities in Germany. 👩‍🔬 Meet our scientist Dr. Yvonne Reiss: Mon & Tue, 12–2 p.m. Stop by, we look forward to connecting with you!
011
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 15/04/2026
📣 Headed to the @theaacr.bsky.social Annual Meeting in San Diego! #AACR2026 Curious about translational colorectal cancer research in our consortium and research opportunities in Germany? 🇩🇪 👉 Booth 3045 – Cancer Research in Germany 📅 April 19–22 🤝 Together with DFG NA, iFIT, SFB1399 and NCT
031
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 25/03/2026
Forschung🔬„Made in Hessen“:👩🏼‍🔬🧑🏽‍🔬v. @loewe-fci.bsky.social untersuchen im #GeorgSpeyerHaus einen #GranatapfelNaturstoff, der #Immuntherapien🆚Krebs stärken💪🏽könnte. 1.📝Studie startet a. d. #UniversitätsmedizinFrankfurt. Die Hessenschau berichtet➡️ www.hessenschau.de/gesellschaft... @goetheuni.bsky.social
093
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 23/03/2026
⏰ Reminder: Abstracts for the Frankfurt Cancer Conference 2026 are due Mar 26! Share your research and connect with leading cancer researchers. 📅 September 2–4, 2026 📍 @Goethe University Frankfurt (Campus Westend) 🔗 www.frankfurtcancerconference.org #FrankfurtCancerConference
frankfurtcancerconference.org
Cancer Conference 2026 - UCT Frankfurt
The Frankfurt Cancer Conference is a meeting of internationally leading cancer researchers in basic and translational as well as clinical research. It's also an ideal forum for early-career scientists...
143
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 17/03/2026
📣 Submit your abstract to the Frankfurt Cancer Conference 2026 (Sept 2–4, @goetheuni.bsky.social) for a chance to give a short talk. 📅 Deadline: March 26 www.frankfurtcancerconference.org Looking forward to our keynote speaker Carl June and an excellent lineup! #FrankfurtCancerConference
143
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 10/03/2026
💬 Join us for a CRC Crosstalk Seminar 💬 “Colorectal cancer heterogeneity – the dark side of plasticity” by Helmuth Gehart, from @ethz.ch 📅 Tuesday, March 24, 2026 🕙 12:00 pm 📍 Lecture Hall, Georg-Speyer-Haus Frankfurt / Hybrid event #TRR417 #CRCcrosstalk #TogetherAgainstColonCancer #ColonCancer
021
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 09/03/2026
📢 Call for Abstracts - Frankfurt Cancer Conference 2026 Present your research September 2-4 as a poster or get selected for a short talk. Share your work, get feedback, and connect at the international #FrankfurtCancerConference. 📆 Deadline: March 26, 2026 🔗 www.frankfurtcancerconference.org
1116
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 05/03/2026
🆕Neue🪐Impulse aus der LOEWE-Forschung: Die🗞️ProLOEWE-NEWS 1. 2026 ist da! #Krebsforschung @loewe-fci.bsky.social, #Zukunftsmedizin, #mentaleGesundheit + ein Blick👀hinter die🎭Kulissen wissenschaftl. Karrieren diesmal Prof. Andreas Gattinger @jlugiessen.bsky.social ➡️ www.linkedin.com/posts/proloe...
0107
Reposted by Ann-Kathrin Mehnert
ProLOEWE @proloewe.bsky.social · 03/03/2026
𝗘𝗶𝗻𝗲𝗻 𝗧𝗮𝗴 𝗮𝗹𝘀👦🏻👧𝗡𝗮𝗰𝗵𝘄𝘂𝗰𝗵𝘀𝘄𝗶𝘀𝘀𝗲𝗻𝘀𝗰𝗵𝗮𝗳𝘁𝗹𝗲𝗿:𝗶𝗻🧪– 𝗱𝗮𝘀 𝗵𝗮𝗯𝗲𝗻 𝗟𝗢𝗘𝗪𝗘-𝗔𝗖𝗟𝗙-𝗜&𝗣𝗿𝗼𝗟𝗢𝗘𝗪𝗘 𝗵𝗲𝘂𝘁𝗲 𝗦𝗰𝗵𝘂̈𝗹𝗲𝗿:𝗶𝗻𝗻𝗲𝗻 𝗶𝗺 𝗔𝗹𝘁𝗲𝗿 𝘃𝗼𝗻 𝟴-𝟭𝟭 𝗝𝗮𝗵𝗿𝗲𝗻 𝗮𝗺 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝗮̈𝘁𝘀𝗸𝗹𝗶𝗻𝗶𝗸𝘂𝗺 𝗙𝗿𝗮𝗻𝗸𝗳𝘂𝗿𝘁 𝗮𝗺 𝗠𝗮𝗶𝗻 𝗲𝗿𝗺𝗼̈𝗴𝗹𝗶𝗰𝗵𝘁! Ein herzliches🫶🏼Danke an alle Beteiligten, die diesen besonderen Tag möglich gemacht haben➡️ www.linkedin.com/feed/update/...
072
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 17/02/2026
📣 Registration and Abstract Submission Open: FRANKFURT CANCER CONFERENCE 2026 Translating Paul Ehrlich’s Magic Bullet into Novel Targeted Therapies 🕗 September 2–4, 2026 📍Campus Westend, @goetheuni.bsky.social, Frankfurt/Main, DE ➡️ frankfurtcancerconference.org #FrankfurtCancerConference
042
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 04/02/2026
Today is #WorldCancerDay!🎗️ Colorectal cancer is among the most common cancers worldwide. At SFB/TRR 417, we study the tumor microenvironment to improve CRC treatment. 👉 Visit LinkedIn for personal insights from our consortium! #TogetherAgainstColonCancer #UnitedByUnique worldcancerday.org
031
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 19/01/2026
Save the Date: FRANKFURT CANCER CONFERENCE 2026 Translating Paul Ehrlich’s Magic Bullet into Novel Targeted Therapies 🕗 Wed., September 2, 2026 – Fri., September 4, 2026 📍Campus Westend, @goetheuni.bsky.social, Frankfurt/Main, DE ➡️ www.frankfurtcancerconference.org #frankfurtcancerconference
054
Reposted by Ann-Kathrin Mehnert
SFB/TRR 417 @trr417.bsky.social · 10/12/2025
🚀 Strong start for our SFB/TRR 417, funded by @dfg.de! Our researchers from @goetheuni.bsky.social, @fau.de, @uni-freiburg.de, @pei.de and Georg-Speyer-Haus gathered to connect and exchange ideas on #ColorectalCancer and the #TumorMicroenvironment. Living up to our motto: #TogetherAgainstColonCancer
063
Reposted by Ann-Kathrin Mehnert
Frankfurt Cancer Institute @loewe-fci.bsky.social · 11/11/2025
Great news: The #LOEWE Center Frankfurt Cancer Institute @goetheuni.bsky.social will continue to receive funding from the state of Hesse! 🎉 12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt. Thank you Hesse and everyone involved!!
084
Reposted by Ann-Kathrin Mehnert
Goethe-Universität Frankfurt @goetheuni.bsky.social · 10/11/2025
Im @loewe-fci.bsky.social arbeiten Forschende gemeinsam an translationaler #Krebsforschung. Nun wird das #FCI weiter vom Land Hessen gefördert: Wissenschaftsminister Timon Gremmels hat heute einen Förderbescheid für die Jahre 2026/27 überreicht. 🔗 Mehr: aktuelles.uni-frankfurt.de/allgemein/12...
153
Ann-Kathrin Mehnert @ak-mehnert.bsky.social · 08/10/2025
🎉 Exciting news: my PhD project @daothilab.bsky.social has been published in #PLoS Pathogens! I investigated how the #hepatitis E virus ORF2 protein counteracts antiviral responses, contributing to persistent viral replication. A huge thank you to all collaborators! 🙏🏻 🔗 share.google/WwIT43Su3KOP...
share.google
The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistent replication in cell culture
Author summary Hepatitis E virus (HEV) is an important yet often underestimated pathogen. Depending on the genotype, HEV infections can progress to chronicity, but the underlying mechanisms remain poo...
083